This MontCo medical devices firm raised a $19.3M Series C led by Safeguard

Written by Roberto Torres, Philly

To date, the company has raised $40.9 million.

King of Prussia-based Trice Medical announced today it closed a $19.3 million Series C round led by Safeguard Scientifics.

The round will go toward accelerating and expanding the company’s U.S. market reach for its flagship product, a handheld diagnostics tool called mi-eye, as well as research and development, sales, marketing and “key international regulatory approvals.”

To date, the company has racked up $40.9 million in ventur capital. Along with previous investors Safeguard and BioStar Ventures, U.K.-based medical company Smith & Nephew joined the list of investors.

Click here to read the full article.

©2020 PACT All Rights Reserved